Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-29 @ 11:43 PM
Study NCT ID:
NCT05584332
Status:
TERMINATED
Last Update Posted:
2023-07-21
First Post:
2022-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
Sponsor:
Shanghai Bovax Biotechnology Co., Ltd.
Organization: